Skin autofluorescence predicts cancer in subjects with type 2 diabetes
Introduction Subjects with type 2 diabetes have an excess risk of cancer. The potential role of advanced glycation end products (AGEs) accumulated during long-term hyperglycemia in cancer development has been suggested by biological studies but clinical data are missing. AGEs can be estimated by mea...
Main Authors: | Laurence Baillet-Blanco, Vincent Rigalleau, Kamel Mohammedi, Ninon Foussard, Alice Larroumet, Marine Rigo, Pauline Poupon, Marie Monlun, Maxime Lecocq, Anne-Claire Devouge, Claire Ducos, Marion Liebart, Quentin Battaglini |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-08-01
|
Series: | BMJ Open Diabetes Research & Care |
Online Access: | https://drc.bmj.com/content/9/1/e001312.full |
Similar Items
-
Skin autofluorescence, a marker of glucose memory in type 2 diabetes
by: Marine Rigo, et al.
Published: (2020-09-01) -
The skin autofluorescence may help to select patients with Type 2 diabetes candidates for screening to revascularization procedures
by: Fadi Alkhami, et al.
Published: (2024-01-01) -
Comment on Peker, T.; Boyraz, B. The Relationship between Resistant Hypertension and Advanced Glycation End-Product Levels Measured Using the Skin Autofluorescence Method: A Case–Control Study. <i>J. Clin. Med.</i> 2023, <i>12</i>, 6606
by: Fadi Alkhami, et al.
Published: (2023-12-01) -
Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study
by: C. Blanc-Bisson, et al.
Published: (2018-06-01) -
Cost-effectiveness of screening of coronary artery disease in patients with type 2 diabetes at a very high cardiovascular risk (SCADIAB) study. Updated study design: emulation of a randomised target trial using electronic health records
by: Kamel Mohammedi, et al.
Published: (2023-11-01)